<DOC>
	<DOCNO>NCT02241460</DOCNO>
	<brief_summary>The purpose study evaluate efficacy treatment Promescent Lidocaine Spray compare placebo patient premature ejaculation .</brief_summary>
	<brief_title>Efficacy Promescent Lidocaine Spray Men With Premature Ejaculation</brief_title>
	<detailed_description>Promescent Lidocaine Spray non-prescription drug market over-the-counter drug monograph ( 21 CFR Section 348.10 Subpart B ( ) ( 2 ) ) male genital desensitize drug product . In addition evaluate efficacy treatment Promescent , study evaluate patient ' subjective distress , perception improvement optimal dose , safety tolerability Promescent patient premature ejaculation respective partner .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Premature Ejaculation</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Subject provide write informed consent screening . Subject male , 18 year age old . Subject meet diagnostic criterion premature ejaculation define DSMIVTR ( Diagnostic Statistical Manual Mental Disorders , 4th Edition , Text Revision ; 2000 ) . Subject stable , monogamous , heterosexual relationship sexually active least last 6 month . Subject partner willing able engage sexual intercourse . Subject never achieve intravaginal ejaculation past 6 month ( i.e. , always ejaculate prior penetration ) . Subject form ejaculatory dysfunction ( e.g. , retrograde ejaculation , anejaculation , painful ejaculation ) . In opinion investigator , subject condition situation may put subject significant risk , may confound study result , may interfere significantly subject 's ability participate study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Premature Ejaculation</keyword>
	<keyword>Lidocaine</keyword>
</DOC>